To the Editor, Endometriosis is a chronic, estrogen-dependent disease, affecting 6%-10% of reproductive-age women [1] . It can be associated with dysmenorrhea, dyspareunia, chronic pelvic pain and infertility. Pain can be severe and negatively affect the quality of life of patients. Although the pathogenesis of endometriosis is still debated, evidences highlight that both the onset and the progression of this disease are supported by an imbalance of invasive, proliferative and adhesive properties of endometrial cells and an increased production of inflammatory molecules. Vitamin D is involved in many processes of the reproductive system; in particular, the endometrium represents an extrarenal site of synthesis of the vitamin, which could influence its cyclical changes. Vitamin D synthesis may also occur in ectopic endometrium probably playing a paracrine effect [2] . In fact, beyond its effect on calcium absorption, vitamin D shows antiproliferative, antiinflammatory and immunomodulatory effects [3] . Vitamin D binds to the vitamin D receptor (VDR) as a ligand-activated transcription factor. VDR is ubiquitous and also expressed in reproductive tissues, including the endometrium [4] . The possible link between endometriosis and vitamin D has been recently investigated because endometriosis often behaves as a malignant disease and shows several characteristics of an autoimmune disease [5, 6] . We evaluated 25-vitamin D levels in women with endometriosis and the potential relationship between these levels and its symptoms.
Between June and November 2015, 135 consecutive outpatients, aged between 18 and 45 years (mean ± SD, 34.7 ± 6.3 years) with surgical and histological confirmed endometriosis, were enrolled in the study. The control group consisted of 90 women without symptoms or clinical and ultrasonographic signs of endometriosis, well matched with the cases for age and body mass index (BMI), meeting the inclusion criteria to the study. All women were Caucasian Italian, living in Rome and referred to the Department of Gynecology and Obstetrics of "Sapienza" University of Rome. Exclusion criteria included current pregnancy, chronic diseases, celiac disease or other causes of malabsorption, menopausal status or disorders that may impact calcium or vitamin D metabolism, kidney diseases, BMI (kg/m 2 ) ≥30, previous therapy with gonadotropin releasing hormone (GnRH) analogs, current hormonal therapy (GnRHa, progestogens or combined estrogen-progestogens), medications affecting bone metabolism, vitamin D or calcium supplementation. One hundred four cases met the including criteria. The study protocol was approved by the Institutional Review Board and all women signed a written informed consent to the study. At the enrolment, medical history was taken and, in order to avoid possible seasonal effects on baseline 25-OH-vitamin D levels, all women came back in July, in the first phase of the cycle, for peripheral blood sample drawing. Analysis of 25-OH-vitamin D was performed by LUMIPULSE ® G1200 (Fujirebio, Japan), an automated assay system based on chemiluminescent enzyme immunoassay (CLEIA) technology. According to the report of the international Osteoporosis Foundation Guidelines, vitamin D status was categorized as deficiency <20 ng/mL, insufficiency 20-30 ng/mL and sufficiency ≥30 ng/mL [7] . Pain was assessed by using a 10-point visual analog scale (VAS) for each pain symptom (dysmenorrhea, dyspareunia and chronic pelvic pain), considering a score of 0 as absence of pain, In women with endometriosis, serum 25-OH-vitamin D level was 21.3 ± 8.9 ng/mL (mean ± SD).
Deficiency of 25-OH-vitamin D was observed in 48% of women, insufficiency in 32% and only 20% had sufficient serum values. Overall, vitamin D deficiency/insufficiency was present in 80% of cases. In the control group, 25-OH-vitamin D level was 32.3 ± 2.67 ng/mL (mean ± SD). Deficiency/insufficiency of 25-OH-vitamin D was significantly more frequent in women with endometriosis than in the control group (80% vs. 33.3%; p < 0.001). A strong correlation with the presence of endometriosis was found (p < 0.001).
At the multiple logistic regression, the presence of any type of pain ≥5 at VAS scale resulted an independent factor associated with the deficiency of 25-OH-vitamin D (odds ratio = 4.4; 95% confidence interval = 1.12-16.84; p = 0.033). Figure 1 shows the significant correlation between low 25-OH vitamin D levels and the presence of any type of pain ≥5 at VAS scale (p < 0.02). No correlation was found between 25-OH vitamin D concentrations and the stage of disease, infertility or BMI.
Briefly, this study showed that women with endometriosis have lower vitamin 25-OH D levels than healthy women of reproductive age. Moreover, insufficient levels of vitamin D significantly correlated with the presence of any kind of moderate/severe pelvic pain; this finding could be related to the lack of modulation of local inflammation due to low amount of vitamin D [8] . The reported effect of Vitamin D administration on pain reduction could be associated with the decrease in prostaglandin synthesis and the increase in prostaglandin inactivation by suppression of cyclo-oxygenase2 and up-regulation of 15-hydroxyl prostaglandin dehydrogenase [9] . In a randomized study on women with primary dysmenorrhea, a single oral dose of cholecalciferol given 5 days before the menstruation was effective in reducing pain [10] . There is an insufficient evidence to establish the causality between vitamin D and endometriosis; "in vitro" 1,25 vitamin D exhibits an antiproliferative effect without inducing apoptosis and increases the expression of survivin, a protein that inhibits apoptosis and regulates cell division [9] . Besides, 1,25(OH) vitamin D exhibits a significant antineoplastic activity influencing the cell growth, differentiation, and apoptosis [11] , probably influencing endometriosis growth. Moreover, Miyashita et al. showed that the addition of 1,25(OH) vitamin D to a culture of endometrioma tissue significantly reduced prostaglandin production, IL-1 or TNF-α-induced inflammatory responses and matrix metalloproteinase (MMP)-2 and MMP-9 expressions [12] .
However, conflicting data have been reported; the reason of the discrepancies between different studies could be related to different study design, selection of patients and analytic methods.
The cause of vitamin D deficiency in endometriosis is still under evaluation. It is possible that the diet gives an important contribution, particularly low dairy foods intake. In a large prospective study, a significantly lower rate of laparoscopically confirmed endometriosis was observed among women with higher plasma 25-OH vitamin D levels and greater intake of dairy foods [13] . Despite the evidences in the literature regarding the possible role of Vitamin D deficiency in infertility, we did not find any significant association; however, this finding could be related to the small number of cases.
The results of this study highlight the role of vitamin D as a possible modifiable risk factor for endometriosis and its symptoms, although a cause-effect relationship is not yet clear.
Further studies are needed to confirm this association, also in order to suggest vitamin D supplementation in women with insufficiency/deficiency of the vitamin and symptomatic endometriosis. Multicenter randomized controlled studies must be conducted to identify the safe dose of vitamin D before recommending vitamin D supplementation in these patients.
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